http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2262529-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_905462d2be95f0580aaa0f1e41944419
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-14
filingDate 1974-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1975-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2262529-A1
titleOfInvention L-arginine acetylsalicylate salt - water soluble and prepd. by direct reaction of arginine and acetylsalicylic acid
abstract A water-soluble salt of L-arginine (I) and acetylsalicylic acid (II) is prepd. by direct reaction of stoichiometric amts. of (I) and (II) pref. in a polar (alcoholic or aq. - alcoholic) solvent. The analgesic and antirheumatic agent (II) is solubilised, and hence its ulcerogenic activity suppressed, without introducing potentially undesirable cations. The salt is completely and quickly assimilated giving high (II) levels. (I) has antianomanic properties with simultaneous proteinising and anabolic actions which promote the detoxifying mechanisms of the liver.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1001443-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0425362-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5360925-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5480999-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0425362-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2685869-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2685916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1006227-A3
priorityDate 1974-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224

Total number of triples: 30.